Investor Network Edge SJA's broad investor network supports private and public fundraising, including Reg CF and Reg A+. This positions the firm as a strong partner for biotech founders seeking seed to growth capital and creates cross-sell opportunities into licensing, strategic partnerships, and M&A advisory.

Non-Dilutive Funding Offering NIH/SBIR and CPRIT non-dilutive capital, SJA can attract grant-focused clients and expand into grant consulting, program navigation, and proposal support as growth drivers.

Comprehensive Service Pack A full-service suite—including private placements, reverse mergers, non-dilutive funding, M&A, and licensing strategy—enables cross-selling across fundraising, corporate development, and licensing deals for life sciences companies.

Lean yet Scalable With a lean team, SJA can scale through partnerships, referral channels, and white-label services to handle larger client volumes without proportional headcount growth.

Marketing Tech Readiness A technology-forward footprint (Squarespace, HubSpot) signals openness to advanced MarTech, investor data services, and automated outreach to boost lead generation and deal velocity.